Do high sensitivity cardiac troponin assays improve patient outcomes?
New study reports benefits for some patients with suspected acute coronary syndrome Cardiac troponins have replaced other blood biomarkers for the diagnosis of myocardial injury. They are widely used to risk stratify patients towards safe early discharge or further investigation of coronary anatomy when clinical and electrocardiographic features are suggestive of acute coronary syndrome. High sensitivity assays can detect lower concentrations of cardiac troponin than older assays, improving test sensitivity and enabling earlier detection of myocardial injury. In practice, use of high sensitivi...